Harrison C Bergeron (H C Bergeron)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Venues

Vaccines

Viruses

PloS one

Therapeutic advances in infectious disease

University of Georgia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Georgia

United States

Graduate Student :: Infectious Diseases

Publications

Z Beau Reneer, Harrison C Bergeron, Stephen Reynolds, Elena Thornhill-Wadolowski, Lan Feng, Marcin Bugno, Agnieszka D Truax, Ralph A Tripp
mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge. PloS one 19 (4) (2024)
Z Beau Reneer, Harrison C Bergeron, Stephen Reynolds, Elena Thornhill-Wadolowski, Lan Feng, Marcin Bugno, Agnieszka D Truax, Ralph A Tripp
mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge. PloS one 19 (4) (2024)
Z Beau Reneer, Harrison C Bergeron, Stephen Reynolds, Elena Thornhill-Wadolowski, Lan Feng, Marcin Bugno, Agnieszka D Truax, Ralph A Tripp
mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge. PloS one 19 (4) (2024)
Z Beau Reneer, Harrison C Bergeron, Stephen Reynolds, Elena Thornhill-Wadolowski, Lan Feng, Marcin Bugno, Agnieszka D Truax, Ralph A Tripp
mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge. PloS one 19 (4) (2024)
Harrison C Bergeron, Matthew R Hansen, Ralph A Tripp
Interferons-Implications in the Immune Response to Respiratory Viruses. Microorganisms 11 (9) (2023)
Harrison C Bergeron, Jackelyn Murray, Aakash Arora, Ana M Nuñez Castrejon, Rebecca M DuBois, Larry J Anderson, Lawrence M Kauvar, Ralph A Tripp
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein. Viruses 15 (5) (2023)
Harrison C Bergeron, Lawrence M Kauvar, Ralph A Tripp
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response. Therapeutic advances in infectious disease 10 (2023)
Harrison C Bergeron, Lawrence M Kauvar, Ralph A Tripp
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response. Therapeutic advances in infectious disease 10 (2023)
Thomas J Powell, Andrea Jacobs, Jie Tang, Edwin Cardenas, Naveen Palath, Jennifer Daniels, James G Boyd, Harrison C Bergeron, Patricia A Jorquera, Ralph A Tripp
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge. Vaccines 10 (12) (2022)
Harrison C Bergeron, Ralph A Tripp
RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein. Viruses 14 (11) (2022)
Jackelyn Murray, Harrison C Bergeron, Les P Jones, Zachary Beau Reener, David E Martin, Fred D Sancilio, Ralph A Tripp
Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Viruses 14 (5) (2022)
Thomas J Powell, Andrea Jacobs, Jie Tang, Edwin Cardenas, Naveen Palath, Jennifer Daniels, James G Boyd, Harrison C Bergeron, Patricia A Jorquera, Ralph A Tripp
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge. Vaccines 10 (12) (2022)
Thomas J Powell, Andrea Jacobs, Jie Tang, Edwin Cardenas, Naveen Palath, Jennifer Daniels, James G Boyd, Harrison C Bergeron, Patricia A Jorquera, Ralph A Tripp
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge. Vaccines 10 (12) (2022)
Thomas J Powell, Andrea Jacobs, Jie Tang, Edwin Cardenas, Naveen Palath, Jennifer Daniels, James G Boyd, Harrison C Bergeron, Patricia A Jorquera, Ralph A Tripp
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge. Vaccines 10 (12) (2022)
Harrison C Bergeron, Zachary Beau Reneer, Aakash Arora, Stephen Reynolds, Tamas Nagy, Ralph A Tripp
Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 Mice. Vaccines 10 (9) (2022)
Harrison C Bergeron, Jackelyn Murray, Ana M Nuñez Castrejon, Rebecca M DuBois, Ralph A Tripp
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies. Viruses 13 (2) (2021)
Harrison C Bergeron, Ralph A Tripp
Immunopathology of RSV: An Updated Review. Viruses 13 (12) (2021)
Harrison C Bergeron, Ralph A Tripp
Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV). Expert opinion on investigational drugs 31 (1) (2021)
Harrison C Bergeron, P S Glas, K R Schumann
Diagnostic specificity of the African swine fever virus antibody detection enzyme-linked immunosorbent assay in feral and domestic pigs in the United States. Transboundary and emerging diseases 64 (6) (2017)

Harrison C Bergeron.css-eqlu8i{font-size:small;padding-left:4px;} (H C Bergeron)

Publication Activity (10 Years)

Top Topics

Top Venues

Harrison C Bergeron (H C Bergeron)